Bluebird Bio Inc (BLUE) 91.28 $BLUE
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio
PR Newswire - Fri Dec 12, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Halozyme Therapeutics Inc. (NASDAQ: HALO), Neurocrine Biosciences Inc. (NASDAQ: NBIX), and Bluebird Bio Inc. (NASDAQ: BLUE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 11, 2014, the NASDAQ Composite ended at 4,708.16, up 0.52%, the Dow Jones Industrial Average advanced 0.36%, to finish the day at 17,596.34, and the S&P 500 closed at 2,035.33, up 0.45%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 806.11, up 0.26%, with the index also advancing 8.67% in the previous three months. Register for your complimentary reports on these five stocks at:
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), ACAD: 32.53 (-0.10), NBIX: 21.97 (+0.12), HALO: 7.99 (-0.16)
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
at The Street - Fri Dec 12, 5:05AM CST
The CEOs of Exact Sciences, Idenix Pharma, Prosensa, Agios, Bluebird Bio and InterMune vie for the coveted title of Best Biotech CEO
BLUE: 91.28 (+5.16), RNA: 18.76 (-0.21), EXAS: 27.96 (-0.24), AGIO: 119.56 (+0.36)
bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:45PM CST
bluebird bio, Inc. gained 72.4% after the company announced encouraging data on eight patients.
BLUE: 91.28 (+5.16), ACT: 259.00 (-4.00), AMGN: 164.53 (-1.55), AMAG: 40.04 (-0.79)
Wedbush Securities' David Nierengarten On Genetic Cures For Disease: Impossible Dream Come True?
Life Sciences Report - at Seeking Alpha - Thu Dec 11, 1:57PM CST
Clinicians like to speak in terms of "managing" disease. That term of art is an admission that, in most cases, they can't cure the serious problems confronting patients. In this interview with The Life Sciences Report , David Nierengarten of...
BLUE: 91.28 (+5.16), AGTC: 20.18 (-1.09), NPSP: 31.28 (-0.99)
Jim Cramer's Top Stock Picks: RH COST AGIO BLUE ISIS
at The Street - Thu Dec 11, 5:00AM CST
Restoration Hardware and Costco should benefit from lower oil prices, and the recent drop in Agios' and Bluebird Bio's shares means a buying opportunity, Cramer says.
BLUE: 91.28 (+5.16), RH: 93.59 (-0.40), ISIS: 62.32 (+0.45), COST: 137.88 (-3.53), AGIO: 119.56 (+0.36)
Cramer's Mad Money - The Good Isis (12/10/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Thu Dec 11, 3:43AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday December 10. CEO Interview: Dr. Stanley Crooke, Isis Pharmaceuticals (NASDAQ: ISIS ) Isis Pharmaceuticals ( ISIS ) produces treatments that bind to...
BLUE: 91.28 (+5.16), TSLA: 207.00 (-1.88), RH: 93.59 (-0.40), FRPT: 17.14 (-0.88), BA: 120.77 (-2.60), CELG: 114.49 (-2.25), XLV: 68.78 (-1.07), RFMD: 15.50 (-0.29), NOV: 61.55 (-1.46), ISIS: 62.32 (+0.45), KITE: 54.79 (+0.39), TQNT: 25.87 (-0.51), COST: 137.88 (-3.53), AGIO: 119.56 (+0.36), VZ: 45.58 (-0.78), CSCO: 26.85 (-0.14)
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices
at The Street - Wed Dec 10, 7:41PM CST
The negative effects of oil below $60 per barrel on certain companies could outweigh the gains seen from higher consumer spending, at least in the short term, Cramer says.
TSLA: 207.00 (-1.88), RH: 93.59 (-0.40), F: 14.99 (-0.29), EMES: 44.67 (+0.92), BOKF: 58.67 (-1.75), FRPT: 17.14 (-0.88), BPT: 67.95 (-2.57), HBHC: 29.40 (-0.82), PBR: 7.11 (-0.31), T: 32.16 (-0.55), CFR: 70.00 (-1.62), SAVE: 68.12 (-0.88), JPM: 60.04 (-1.10), COST: 137.88 (-3.53), XLF: 24.14 (-0.48), BLUE: 91.28 (+5.16), BA: 120.77 (-2.60), CELG: 114.49 (-2.25), ISIS: 62.32 (+0.45), KITE: 54.79 (+0.39), CONN: 17.44 (+0.35), JCP: 6.38 (+0.29), GM: 31.57 (-0.62), AGIO: 119.56 (+0.36), PAY: 33.01 (-1.47)
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 10, 2:10PM CST
Yet another acquisition agreement was announced even as the biotech sector was busy with showcasing data at ASH.
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), VRTX: 118.55 (-2.23), CBST: 96.31 (+0.04), INCY: 74.65 (-1.27), AMGN: 164.53 (-1.55), ARRY: 4.86 (-0.04)
Bluebird Bio's
at Investor's Business Daily - Tue Dec 09, 5:33PM CST
Bluebird Bio's (BLUE) "moment has arrived," Cowen & Co. said in a report, which found that 2 patients with a killer blood disease have been able to forgo transfusions for 5 months because of the gene therapy firm's technique. Shares surged 72.4% to...
BLUE: 91.28 (+5.16)
Small Caps a Saving Grace for Stocks as Global Woes Weigh on S&P 500
at The Street - Tue Dec 09, 3:17PM CST
It's China and Greece, not oil, receiving the bulk of blame for a selloff which saddled U.S. indices with triple-digit losses at one point over Tuesday's session.
BLUE: 91.28 (+5.16), HK: 2.01 (-0.09), CAM: 45.62 (-0.97), FEZ: 37.21 (-0.97), C: 53.40 (-1.11), HAL: 37.93 (-0.30), BAC: 17.13 (-0.34), NBG: 1.79 (-0.01), TPLM: 4.06 (-0.18), MS: 36.25 (-1.15), JPM: 60.04 (-1.10), AZO: 604.73 (+2.34), GDP: 3.93 (-0.33), PQ: 3.46 (-0.11), ANF: 27.76 (+0.46), CONN: 17.44 (+0.35), HRB: 31.96 (+0.20), BHI: 54.99 (-0.78)
Sangamo rides bluebird's wave
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 2:45PM CST
BLUE: 91.28 (+5.16), SGMO: 16.53 (+2.46)
S&P 500 Pares Losses as Small Caps and Oil Exploration Stocks Spike
at The Street - Tue Dec 09, 1:12PM CST
The S&P 500 recovers from session lows on Tuesday in a volatile trading session which saw stocks plummet as part of a global market selloff.
HK: 2.01 (-0.09), FEZ: 37.21 (-0.97), CAM: 45.62 (-0.97), DAL: 47.68 (-0.65), C: 53.40 (-1.11), JBLU: 14.81 (-0.48), NBG: 1.79 (-0.01), LUV: 41.41 (-0.51), SAVE: 68.12 (-0.88), GDP: 3.93 (-0.33), ANF: 27.76 (+0.46), AAL: 49.97 (-0.56), TMUS: 25.31 (-0.33), BHI: 54.99 (-0.78), HRB: 31.96 (+0.20), BLUE: 91.28 (+5.16), HAL: 37.93 (-0.30), BAC: 17.13 (-0.34), TPLM: 4.06 (-0.18), MS: 36.25 (-1.15), GS: 188.82 (-4.72), AZO: 604.73 (+2.34), PQ: 3.46 (-0.11), CONN: 17.44 (+0.35)
Bluebird Bio Stock Spikes On New Blood Treatment
at Investor's Business Daily - Tue Dec 09, 1:10PM CST
Biotech Bluebird Bio (BLUE) saw its stock fly to an all-time high Tuesday following a researcher's report from the annual meeting of the American Society of Hematology that two patients with a killer blood disease have been able to forgo blood...
BLUE: 91.28 (+5.16), CELG: 114.49 (-2.25)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST
BLUE: 91.28 (+5.16), SC: 17.65 (-0.71), ANV: 0.74 (-0.04), UTIW: 11.07 (-0.33), AKAO: 11.91 (-0.31), CLDN: 17.25 (+0.75), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TTI: 5.06 (-0.34), TPLM: 4.06 (-0.18), CGIX: 6.30 (unch), LCI: 43.58 (-0.46), SAVE: 68.12 (-0.88), PQ: 3.46 (-0.11), AFMD: 5.38 (-0.34), ENSV: 1.48 (-0.02), CTC: 0.77 (+0.01), CONN: 17.44 (+0.35), PDCE: 33.13 (-0.89), KPTI: 34.85 (+1.35)
Cramer Dubs Bluebird Bio a 'Winner' but Says to Avoid Conn's
at The Street - Tue Dec 09, 10:11AM CST
Jim Cramer says Bluebird Bio's presentation at the American Society of Hematology was very impressive, but Conn's earnings report has too many questions marks.
BLUE: 91.28 (+5.16), HD: 99.78 (-0.49), CONN: 17.44 (+0.35), COST: 137.88 (-3.53), LOW: 64.87 (-0.89)
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver
PR Newswire - Tue Dec 09, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MBLY, BLUE, ISIS, CSLT and COP.
BLUE: 91.28 (+5.16), ISIS: 62.32 (+0.45), COP: 62.45 (-1.16), CSLT: 12.17 (-0.73), MBLY: 40.78 (-1.19)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 8:09AM CST
CANF: 3.49 (+0.03), BLUE: 91.28 (+5.16), NOAH: 19.67 (+0.39), ANV: 0.74 (-0.04), SAVE: 68.12 (-0.88), TLM: 4.29 (+0.60), ANF: 27.76 (+0.46), CONN: 17.44 (+0.35), IAG: 2.57 (+0.06), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TASR: 23.19 (unch), DGLY: 15.55 (+1.34)
Stock Futures Aim Sharply Lower; China Stocks, ETFs Take Heat
at Investor's Business Daily - Tue Dec 09, 8:06AM CST
The market was poised for a tough open Tuesday, as stock futures posted accelerating losses, shadowing sell-offs in Europe and China and as oil and gas prices failed to rebound from Monday's sharp decline. Dow futures were a weighty 147.8 points...
BLUE: 91.28 (+5.16), NOAH: 19.67 (+0.39), BIDU: 229.32 (+0.09), CAF: 28.71 (-0.25), CONN: 17.44 (+0.35), ASHR: 33.43 (-0.63), BABA: 105.11 (+0.14)
bluebird bio (BLUE) in Focus: Stock Surges 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:44AM CST
bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 9% on the day
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), ILMN: 184.30 (-2.53), AFFX: 8.94 (-0.36)
bluebird bio's LentiGlobin delivers impressive results in beta-thalassemia, shares jump
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 6:54AM CST
BLUE: 91.28 (+5.16)
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio
PR Newswire - Fri Dec 12, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Halozyme Therapeutics Inc. (NASDAQ: HALO), Neurocrine Biosciences Inc. (NASDAQ: NBIX), and Bluebird Bio Inc. (NASDAQ: BLUE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 11, 2014, the NASDAQ Composite ended at 4,708.16, up 0.52%, the Dow Jones Industrial Average advanced 0.36%, to finish the day at 17,596.34, and the S&P 500 closed at 2,035.33, up 0.45%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 806.11, up 0.26%, with the index also advancing 8.67% in the previous three months. Register for your complimentary reports on these five stocks at:
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), ACAD: 32.53 (-0.10), NBIX: 21.97 (+0.12), HALO: 7.99 (-0.16)
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
at The Street - Fri Dec 12, 5:05AM CST
The CEOs of Exact Sciences, Idenix Pharma, Prosensa, Agios, Bluebird Bio and InterMune vie for the coveted title of Best Biotech CEO
BLUE: 91.28 (+5.16), RNA: 18.76 (-0.21), EXAS: 27.96 (-0.24), AGIO: 119.56 (+0.36)
bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:45PM CST
bluebird bio, Inc. gained 72.4% after the company announced encouraging data on eight patients.
BLUE: 91.28 (+5.16), ACT: 259.00 (-4.00), AMGN: 164.53 (-1.55), AMAG: 40.04 (-0.79)
Wedbush Securities' David Nierengarten On Genetic Cures For Disease: Impossible Dream Come True?
Life Sciences Report - at Seeking Alpha - Thu Dec 11, 1:57PM CST
Clinicians like to speak in terms of "managing" disease. That term of art is an admission that, in most cases, they can't cure the serious problems confronting patients. In this interview with The Life Sciences Report , David Nierengarten of...
BLUE: 91.28 (+5.16), AGTC: 20.18 (-1.09), NPSP: 31.28 (-0.99)
Jim Cramer's Top Stock Picks: RH COST AGIO BLUE ISIS
at The Street - Thu Dec 11, 5:00AM CST
Restoration Hardware and Costco should benefit from lower oil prices, and the recent drop in Agios' and Bluebird Bio's shares means a buying opportunity, Cramer says.
BLUE: 91.28 (+5.16), RH: 93.59 (-0.40), ISIS: 62.32 (+0.45), COST: 137.88 (-3.53), AGIO: 119.56 (+0.36)
Cramer's Mad Money - The Good Isis (12/10/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Thu Dec 11, 3:43AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday December 10. CEO Interview: Dr. Stanley Crooke, Isis Pharmaceuticals (NASDAQ: ISIS ) Isis Pharmaceuticals ( ISIS ) produces treatments that bind to...
BLUE: 91.28 (+5.16), TSLA: 207.00 (-1.88), RH: 93.59 (-0.40), FRPT: 17.14 (-0.88), BA: 120.77 (-2.60), CELG: 114.49 (-2.25), XLV: 68.78 (-1.07), RFMD: 15.50 (-0.29), NOV: 61.55 (-1.46), ISIS: 62.32 (+0.45), KITE: 54.79 (+0.39), TQNT: 25.87 (-0.51), COST: 137.88 (-3.53), AGIO: 119.56 (+0.36), VZ: 45.58 (-0.78), CSCO: 26.85 (-0.14)
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices
at The Street - Wed Dec 10, 7:41PM CST
The negative effects of oil below $60 per barrel on certain companies could outweigh the gains seen from higher consumer spending, at least in the short term, Cramer says.
TSLA: 207.00 (-1.88), RH: 93.59 (-0.40), F: 14.99 (-0.29), EMES: 44.67 (+0.92), BOKF: 58.67 (-1.75), FRPT: 17.14 (-0.88), BPT: 67.95 (-2.57), HBHC: 29.40 (-0.82), PBR: 7.11 (-0.31), T: 32.16 (-0.55), CFR: 70.00 (-1.62), SAVE: 68.12 (-0.88), JPM: 60.04 (-1.10), COST: 137.88 (-3.53), XLF: 24.14 (-0.48), BLUE: 91.28 (+5.16), BA: 120.77 (-2.60), CELG: 114.49 (-2.25), ISIS: 62.32 (+0.45), KITE: 54.79 (+0.39), CONN: 17.44 (+0.35), JCP: 6.38 (+0.29), GM: 31.57 (-0.62), AGIO: 119.56 (+0.36), PAY: 33.01 (-1.47)
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Dec 10, 2:10PM CST
Yet another acquisition agreement was announced even as the biotech sector was busy with showcasing data at ASH.
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), VRTX: 118.55 (-2.23), CBST: 96.31 (+0.04), INCY: 74.65 (-1.27), AMGN: 164.53 (-1.55), ARRY: 4.86 (-0.04)
Bluebird Bio's
at Investor's Business Daily - Tue Dec 09, 5:33PM CST
Bluebird Bio's (BLUE) "moment has arrived," Cowen & Co. said in a report, which found that 2 patients with a killer blood disease have been able to forgo transfusions for 5 months because of the gene therapy firm's technique. Shares surged 72.4% to...
BLUE: 91.28 (+5.16)
Small Caps a Saving Grace for Stocks as Global Woes Weigh on S&P 500
at The Street - Tue Dec 09, 3:17PM CST
It's China and Greece, not oil, receiving the bulk of blame for a selloff which saddled U.S. indices with triple-digit losses at one point over Tuesday's session.
BLUE: 91.28 (+5.16), HK: 2.01 (-0.09), CAM: 45.62 (-0.97), FEZ: 37.21 (-0.97), C: 53.40 (-1.11), HAL: 37.93 (-0.30), BAC: 17.13 (-0.34), NBG: 1.79 (-0.01), TPLM: 4.06 (-0.18), MS: 36.25 (-1.15), JPM: 60.04 (-1.10), AZO: 604.73 (+2.34), GDP: 3.93 (-0.33), PQ: 3.46 (-0.11), ANF: 27.76 (+0.46), CONN: 17.44 (+0.35), HRB: 31.96 (+0.20), BHI: 54.99 (-0.78)
Sangamo rides bluebird's wave
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 2:45PM CST
BLUE: 91.28 (+5.16), SGMO: 16.53 (+2.46)
S&P 500 Pares Losses as Small Caps and Oil Exploration Stocks Spike
at The Street - Tue Dec 09, 1:12PM CST
The S&P 500 recovers from session lows on Tuesday in a volatile trading session which saw stocks plummet as part of a global market selloff.
HK: 2.01 (-0.09), FEZ: 37.21 (-0.97), CAM: 45.62 (-0.97), DAL: 47.68 (-0.65), C: 53.40 (-1.11), JBLU: 14.81 (-0.48), NBG: 1.79 (-0.01), LUV: 41.41 (-0.51), SAVE: 68.12 (-0.88), GDP: 3.93 (-0.33), ANF: 27.76 (+0.46), AAL: 49.97 (-0.56), TMUS: 25.31 (-0.33), BHI: 54.99 (-0.78), HRB: 31.96 (+0.20), BLUE: 91.28 (+5.16), HAL: 37.93 (-0.30), BAC: 17.13 (-0.34), TPLM: 4.06 (-0.18), MS: 36.25 (-1.15), GS: 188.82 (-4.72), AZO: 604.73 (+2.34), PQ: 3.46 (-0.11), CONN: 17.44 (+0.35)
Bluebird Bio Stock Spikes On New Blood Treatment
at Investor's Business Daily - Tue Dec 09, 1:10PM CST
Biotech Bluebird Bio (BLUE) saw its stock fly to an all-time high Tuesday following a researcher's report from the annual meeting of the American Society of Hematology that two patients with a killer blood disease have been able to forgo blood...
BLUE: 91.28 (+5.16), CELG: 114.49 (-2.25)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:45AM CST
BLUE: 91.28 (+5.16), SC: 17.65 (-0.71), ANV: 0.74 (-0.04), UTIW: 11.07 (-0.33), AKAO: 11.91 (-0.31), CLDN: 17.25 (+0.75), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TTI: 5.06 (-0.34), TPLM: 4.06 (-0.18), CGIX: 6.30 (unch), LCI: 43.58 (-0.46), SAVE: 68.12 (-0.88), PQ: 3.46 (-0.11), AFMD: 5.38 (-0.34), ENSV: 1.48 (-0.02), CTC: 0.77 (+0.01), CONN: 17.44 (+0.35), PDCE: 33.13 (-0.89), KPTI: 34.85 (+1.35)
Cramer Dubs Bluebird Bio a 'Winner' but Says to Avoid Conn's
at The Street - Tue Dec 09, 10:11AM CST
Jim Cramer says Bluebird Bio's presentation at the American Society of Hematology was very impressive, but Conn's earnings report has too many questions marks.
BLUE: 91.28 (+5.16), HD: 99.78 (-0.49), CONN: 17.44 (+0.35), COST: 137.88 (-3.53), LOW: 64.87 (-0.89)
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver
PR Newswire - Tue Dec 09, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MBLY, BLUE, ISIS, CSLT and COP.
BLUE: 91.28 (+5.16), ISIS: 62.32 (+0.45), COP: 62.45 (-1.16), CSLT: 12.17 (-0.73), MBLY: 40.78 (-1.19)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 8:09AM CST
CANF: 3.49 (+0.03), BLUE: 91.28 (+5.16), NOAH: 19.67 (+0.39), ANV: 0.74 (-0.04), SAVE: 68.12 (-0.88), TLM: 4.29 (+0.60), ANF: 27.76 (+0.46), CONN: 17.44 (+0.35), IAG: 2.57 (+0.06), MZOR: 14.30 (+0.10), NBG: 1.79 (-0.01), TASR: 23.19 (unch), DGLY: 15.55 (+1.34)
Stock Futures Aim Sharply Lower; China Stocks, ETFs Take Heat
at Investor's Business Daily - Tue Dec 09, 8:06AM CST
The market was poised for a tough open Tuesday, as stock futures posted accelerating losses, shadowing sell-offs in Europe and China and as oil and gas prices failed to rebound from Monday's sharp decline. Dow futures were a weighty 147.8 points...
BLUE: 91.28 (+5.16), NOAH: 19.67 (+0.39), BIDU: 229.32 (+0.09), CAF: 28.71 (-0.25), CONN: 17.44 (+0.35), ASHR: 33.43 (-0.63), BABA: 105.11 (+0.14)
bluebird bio (BLUE) in Focus: Stock Surges 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:44AM CST
bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 9% on the day
BLUE: 91.28 (+5.16), BIIB: 344.49 (+2.16), ILMN: 184.30 (-2.53), AFFX: 8.94 (-0.36)
bluebird bio's LentiGlobin delivers impressive results in beta-thalassemia, shares jump
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 6:54AM CST
BLUE: 91.28 (+5.16)
